Skip to main content
search
All Posts By

Ben Kemp

Regulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

APHA – Extra border checks cancelled ahead of UK-EU deal

At the UK-EU summit on 19 May, the UK and EU announced that we will agree a Sanitary and Phytosanitary (SPS) Agreement to make agrifood trade with our biggest market cheaper and easier, cutting costs and red tape for British producers and retailers. You can see full details of the announcements here: UK/EU Summit - Key documentation - GOV.UK In…
Ben Kemp
August 21, 2025
ConsultationsConsultations ArchiveMembership NewsMembership News Archive

Reminder: Pathology Managed Service Contracts Call for Evidence closes 5th September

A reminder to all members that the Pathology Managed Service Contracts Call for Evidence closes 5th September. BIVDA has pressed government on this issue for a long time. This, therefore, provides a crucial opportunity to help DHSC with the development of policy guidance in this area. We are encouraged by member engagement so far, following two webinars with Head of…
Ben Kemp
August 20, 2025
Membership NewsMembership News Archive

BIVDA and members meet with Professor Sir Chris Whitty

On Monday 18th August, BIVDA chaired a meeting between Professor Sir Chris Whitty and his policy and delivery teams, and the BIVDA members who had been involved in an industry consensus statement entitled “Unlocking Our Communities Diagnostic Potential”. BIVDA’s report underlines the key opportunities to support the adoption of point-of-care testing in primary care and community care settings. Initially, when…
Ben Kemp
August 20, 2025
HighlightsHighlights Archive

Media Monitoring: 14th – 20th August

Researchers restore antibiotic effect in the event of resistance Bacterial resistance negates the effect of antibiotics in the treatment of infection. Using mouse models, researchers now show that if antibiotics are administered with an enzyme called endolysin, the combined effect protects against infection by resistant bacteria in all bodily organs – including the brain, which antibiotics alone have difficulty reaching.…
Ben Kemp
August 20, 2025
Membership NewsMembership News Archive

Health Minister acknowledges BIVDA’s advocacy work to incorporate diagnostics into antibiotic prescribing

Steve Race MP, who authored the foreword to BIVDA’s Community Diagnostics Consensus Statement, has confirmed that Health Minister Ashley Dalton has formally acknowledged the report. The Minister expressed her thanks to BIVDA and our partner organisations for championing the adoption of diagnostic testing to support appropriate antibiotic prescribing, and commended BIVDA’s wider efforts to tackle antimicrobial resistance (AMR). She also…
Ben Kemp
August 20, 2025
Membership NewsMembership News Archive

Contribute to academic research on single-use diagnostic waste

Academic researchers are seeking contributions on the the research topic, “Towards an Eco-Friendly Future for Microfluidics, Lab-on-a-Chip and Point-of-Care Devices”, to be published in Frontiers in Lab on a Chip Technologies. It now has extended its submission deadline to 31 October 2025. They are calling for engineers, economists, healthcare professionals, manufacturers, regulators and policy makers to join forces and work…
Ben Kemp
August 19, 2025
Membership NewsMembership News Archive

WHO releases TPP for IVDs for serious bacterial infection, including neonatal sepsis, among young infants

The World Health Organization (WHO) has developed a target product profile (TPP) for serious bacterial infection among young infants. This includes neonatal sepsis, which kills 15% of the estimated 2.3 million newborns who die annually. It is estimated that 84% of newborn deaths due to infection could be averted through early diagnosis and appropriate clinical management. However, diagnostic tests for…
Ben Kemp
August 19, 2025
HighlightsHighlights Archive

WHO Collaborating Centre for Genomic Surveillance of AMR launches in London

The WHO Collaborating Centre for Genomic Surveillance of Antimicrobial Resistance (AMR) has been launched at the Royal Institution in London. Hosted by the Centre for Genomic Pathogen Surveillance at Oxford’s Pandemic Sciences Institute, the Centre will help expand and standardise global genomic monitoring of AMR. Designated by WHO, it will develop laboratory protocols, bioinformatics tools and technical guidance, supporting the…
Ben Kemp
August 18, 2025
Close Menu